Table 1.
Baseline characteristics of the study population.
| Overall | Total | Survivor | Total | Non-Survivor | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Median | IQR | n = | Median | IQR | n = | Median | IQR | n = | p = | |
| Age (years) | 57.00 | 19.00 | 93 | 51.50 | 25.50 | 26 | 57.00 | 16.00 | 67 | 0.17 |
| BMI (kg/m2) | 26.37 | 4.58 | 64 | 26.23 | 4.11 | 13 | 27.34 | 5.27 | 51 | 0.17 |
| CPR Duration (min) | 35.00 | 45.00 | 67 | 30.00 | 37.50 | 20 | 40.00 | 50.00 | 47 | 0.52 |
| Baseline C-reactive protein (mg/L) | 13.00 | 40.10 | 63 | 9.40 | 44.35 | 13 | 13.60 | 41.48 | 50 | 0.49 |
| Baseline serum creatine (µmol/L) | 9.82 | 3.06 | 93 | 10.70 | 3.09 | 26 | 9.34 | 3.06 | 67 | 0.02 |
| Baseline hemoglobin (g/dL) | 1.33 | 1.05 | 93 | 1.24 | 0.54 | 26 | 1.50 | 1.23 | 67 | 0.17 |
| Baseline serum lactate (mmol/L) | 9.30 | 8.30 | 93 | 6.30 | 6.17 | 26 | 11.40 | 7.80 | 67 | <0.001 |
| Lactate 6 h (mmol/L) | 8.00 | 9.75 | 93 | 5.45 | 6.81 | 26 | 9.80 | 9.80 | 67 | 0.001 |
| Lactate 12 h (mmol/L) | 6.07 | 8.60 | 86 | 3.75 | 4.78 | 26 | 7.55 | 10.65 | 60 | 0.01 |
| Lactate 24 h (mmol/L) | 4.33 | 5.08 | 80 | 3.70 | 3.30 | 25 | 4.70 | 6.00 | 55 | 0.01 |
| Lactate Clearance 6 h (%) | 11.76 | 53.19 | 93 | 21.97 | 50.22 | 26 | 6.38 | 56.03 | 67 | 0.42 |
| Lactate Clearance 12 h (%) | 22.58 | 72.08 | 86 | 36.20 | 78.94 | 26 | 21.08 | 66.08 | 60 | 0.49 |
| Lactate Clearance 24 h (%) | 46.33 | 54.13 | 80 | 46.15 | 54.94 | 25 | 46.51 | 55.75 | 55 | 0.98 |
| Baseline ALAT (µmol/ls) | 2.87 | 4.04 | 60 | 1.47 | 4.13 | 13 | 3.02 | 3.75 | 47 | 0.22 |
| Baseline Troponin (ng/L) | 1212.00 | 8396.00 | 79 | 1580.00 | 8285.00 | 20 | 723.00 | 10,688.75 | 59 | 0.37 |
| ECs total (n) | 12.00 | 16.00 | 92 | 15.00 | 24.75 | 26 | 12.00 | 15.25 | 66 | 0.36 |
| FFP total (n) | 4.00 | 16.00 | 93 | 6.50 | 18.50 | 26 | 2.00 | 12.00 | 67 | 0.20 |
| ECMO flow 12 h (L/min) | 4.50 | 1.44 | 74 | 4.54 | 1.83 | 18 | 4.50 | 1.37 | 56 | 0.87 |
| n = | % | n = | n = | % | n = | n = | % | n = | p = | |
| IHCA | 39 | 60% | 65 | 8 | 62% | 13 | 31 | 60% | 52 | 1.00 |
| Female | 22 | 24% | 93 | 5 | 19% | 26 | 17 | 25% | 67 | 0.60 |
| Peripheral arterial disease | 8 | 9% | 91 | 1 | 4% | 24 | 7 | 10% | 67 | 0.68 |
| Coronary artery disease | 68 | 76% | 90 | 19 | 76% | 25 | 49 | 75% | 65 | 1.00 |
| Prior myocardial infarction | 8 | 13% | 64 | 1 | 8% | 13 | 7 | 14% | 51 | 1.00 |
| Prior CABG | 3 | 5% | 65 | 0 | 0% | 13 | 3 | 6% | 52 | 1.00 |
| Diabetes mellitus | 21 | 24% | 89 | 4 | 16% | 25 | 17 | 27% | 64 | 0.41 |
| Chronic renal failure | 12 | 18% | 65 | 3 | 23% | 13 | 9 | 17% | 52 | 0.69 |
| Prior stroke | 6 | 9% | 65 | 2 | 15% | 13 | 4 | 8% | 52 | 0.59 |
| Noradrenalin 1 d | 75 | 81% | 93 | 15 | 58% | 26 | 60 | 90% | 67 | 0.001 |
| Dobutamin 1 d | 52 | 56% | 93 | 8 | 31% | 26 | 44 | 66% | 67 | 0.005 |
| Suprarenin 1 d | 43 | 46% | 93 | 15 | 58% | 26 | 28 | 42% | 67 | 0.25 |
BMI: body mass index; CPR: cardiopulmonary resuscitation; ALAT: alanine aminotransferase; ECs: erythrocyte concentrates; FFP, fresh frozen plasma; IHAC: in-hospital cardiac arrest; CABG: coronary artery bypass graft; ECMO, extracorporeal membrane oxygenation; IQR, interquartile range.